Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 578,231 | 347,358 | 176,587 | 562,527 | 435,797 |
| Depreciation Amortization | 259,583 | 178,516 | 78,975 | 295,449 | 220,926 |
| Income taxes - deferred | -60,325 | -17,715 | -14,842 | -149,001 | -156,918 |
| Accounts receivable | -282,518 | -157,758 | -37,856 | -146,892 | -73,878 |
| Other Working Capital | -239,215 | -327,556 | -306,196 | 169,774 | 204,904 |
| Other Operating Activity | 596,301 | 414,170 | 199,841 | 510,264 | 361,906 |
| Operating Cash Flow | $852,057 | $437,015 | $96,509 | $1,242,121 | $992,737 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -418,214 | -196,633 | -97,707 | -321,955 | -211,245 |
| Purchase Of Investment | -825,950 | -684,109 | -452,150 | -1,760,220 | N/A |
| Sale Of Investment | 772,058 | 624,227 | 172,845 | 739,867 | -769,956 |
| Other Investing Activity | -29,074 | -80,933 | 9,996 | -61,307 | -41,308 |
| Investing Cash Flow | $-501,180 | $-337,448 | $-367,016 | $-1,403,615 | $-1,022,509 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 421,093 | 366,737 | 231,552 | 526,861 | 431,606 |
| Common Stock Repurchased | -821,354 | -575,749 | N/A | -201,345 | -195,274 |
| Financing Cash Flow | $-400,261 | $-209,012 | $231,552 | $325,516 | $236,332 |
| Beginning Cash Position | 372,152 | 372,152 | 372,152 | 208,130 | 208,130 |
| End Cash Position | 322,768 | 262,707 | 333,197 | 372,152 | 414,690 |
| Net Cash Flow | $-49,384 | $-109,445 | $-38,955 | $164,022 | $206,560 |
| Free Cash Flow | |||||
| Operating Cash Flow | 852,057 | 437,015 | 96,509 | 1,242,121 | 992,737 |
| Capital Expenditure | -418,214 | -196,633 | -97,707 | -321,955 | -211,245 |
| Free Cash Flow | 433,843 | 240,382 | -1,198 | 920,166 | 781,492 |